WPI 3355 (Nateglinide 120 mg)
Pill with imprint WPI 3355 is Pink, Capsule-shape and has been identified as Nateglinide 120 mg. It is supplied by Watson Laboratories Inc..
Nateglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Nateglinide 120 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3355
Nateglinide
- Imprint:
- WPI 3355
- Strength:
- 120 mg
- Color:
- Pink
- Size:
- 17.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Meglitinides
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Laboratories Inc.
- National Drug Code (NDC):
- 00591-3355
- Inactive Ingredients:
-
- silicon dioxide
- fumaric acid
- hypromellose 2910 (3 mPa.s)
- lactose monohydrate
- magnesium stearate
- polysorbate 80
- sodium starch glycolate type A potato
- corn starch
- titanium dioxide
- hypromellose 2910 (6 mPa.s)
- FD&C Red No. 40
- ferric oxide red
- ferrosoferric oxide
Note: Inactive ingredients may vary.
More about nateglinide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: meglitinides
Consumer resources
Other brands: Starlix
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
